Your session is about to expire
Carvedilol vs Metoprolol
Introduction
For patients with high blood pressure, heart failure, or those who have recently suffered a heart attack, certain drugs that help manage the rate and rhythm of heartbeat can provide relief and improve health outcomes. Carvedilol and Metoprolol are two such drugs that are typically prescribed for these conditions. Both medications belong to the class of beta-blockers which work by blocking the effects of adrenaline on your body's beta-receptors thereby reducing stress on the heart.
Carvedilol is unique in its capacity as it blocks both alpha-1 and beta receptors whereas Metoprolol primarily targets beta-1 receptors only. This dual-action mechanism allows Carvedilol to decrease peripheral vascular resistance along with slowing down the heart rate making it beneficial for patients with congestive heart failure.
On the other hand, Metoprolol is more cardioselective (primarily affecting beta-1 adrenergic receptors) hence tends to have less impact on lung function which makes it a preferable choice for individuals suffering from respiratory issues like asthma or COPD alongside their cardiovascular disease.
Carvedilol vs Metoprolol Side By Side
| Attribute | Coreg | Lopressor toprol xl |
|---|---|---|
| Brand Name | Coreg | Lopressor, Toprol XL |
| Contraindications | Severe liver disease, worsening symptoms of heart failure such as shortness of breath, swelling ankles/feet, or unusual tiredness or weight gain. | Severe liver disease, abrupt discontinuation can lead to rapid worsening of angina symptoms. |
| Cost | Generic carvedilol can be found with prices ranging from as low as $0.10 to up to $1 per day. | Metoprolol succinate's pricing starts at roughly at about $0.15/day and can go up to approximately $.90/day. |
| Generic Name | Carvedilol | Metoprolol |
| Most Serious Side Effect | Severe liver damage, hypersensitivity reactions such as skin rash, itching or hives, swelling of the face or hands and lips. | Signs of a serious allergic reaction such as hives; difficulty breathing; swelling in your face, lips, tongue or throat. |
| Severe Drug Interactions | Calcium channel blockers (verapamil and diltiazem), class I antiarrhythmics (disopyramide) and centrally acting antihypertensive drugs. | Calcium channel blockers (verapamil and diltiazem), class I antiarrhythmics (disopyramide) and centrally acting antihypertensive drugs. |
| Typical Dose | Starts from 3.125 mg twice a day for heart failure, up to 50 mg per day for hypertension. | Typically initiated at 25-100 mg/day, up to 400 mg/day, divided into two doses. |
What is Carvedilol?
Carvedilol (the generic name for Coreg) is a distinctive medication from the class of beta blockers. It was first approved by the FDA in 1995 to treat heart failure and hypertension. Carvedilol works by blocking both alpha and beta receptors, which leads to vasodilation, thus decreasing blood pressure and reducing the workload on the heart. It's often prescribed for conditions such as high blood pressure and post-heart attack treatment.
On the other hand, Metoprolol (brand names include Lopressor or Toprol XL) also belongs to this class but only blocks beta-1 receptors specifically located in the heart muscle cells; therefore it has less influence over lung function compared to carvedilol. This selective action makes metoprolol a better choice for patients with chronic obstructive pulmonary disease or asthma. However, like all medications, each one carries its own risk profile including potential side effects that should be discussed with your healthcare provider.
What conditions is Carvedilol approved to treat?
Carvedilol is approved for the management of various heart conditions including:
- Heart failure
- Left ventricular dysfunction following myocardial infarction (heart attack)
- Hypertension, also known as high blood pressure
On the other hand, Metoprolol is used to treat:
- Angina pectoris (chest pain due to heart disease)
- Hypertension
- Acute myocardial infarction These two medications have overlapping uses but are not completely interchangeable and should be prescribed by a healthcare professional based on each individual's unique medical history.
How does Carvedilol help with these illnesses?
Carvedilol manages heart conditions by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect reduces heart rate, blood pressure, and strain on the heart. Carvedilol is a type of drug known as a beta blocker, which works by inhibiting the effects of adrenaline (epinephrine) on your body's beta receptors. By doing this it decreases the force with which the heart muscle contracts and reduces its oxygen needs. It also dilates (widens) blood vessels to improve your blood flow and decrease vascular resistance.
Epinephrine is a neurotransmitter that plays an important role in regulating heartbeat strength and speed, narrowing or widening arteries for optimal circulation based upon current demands. Individuals with certain cardiovascular diseases often have their bodies excessively release epinephrine causing high levels of stress to their hearts over time.
By reducing these negative effects caused by excess epinephrine release within our bodies' cardiovascular system through its mechanism of action as outlined above; Carvedilol assists patients in better managing their condition(s), stabilizing their circulatory system function thus improving overall health outcomes.
What is Metoprolol?
Metoprolol, marketed under the brand name Lopressor among others, is a selective β1 receptor blocker medication. This means it blocks the action of certain chemicals in the heart and blood vessels to lower blood pressure, slow heart rate and reduce strain on the heart following a heart attack. Metoprolol was first approved by the FDA in 1978.
Unlike Carvedilol which affects both α1 and β receptors (non-selective), Metoprolol selectively inhibits activation of β1 receptors thereby reducing side effects associated with other nonselective beta blockers such as fatigue, cold hands or feet, weight gain or depression. It's worth noting that while both medications are used to treat high blood pressure and chest pain due to angina, only metoprolol has been found effective for preventing migraine headaches.
Common side-effects can still include drowsiness or tiredness but its selectivity tends to make it better tolerated compared with nonselective beta blockers like Carvedilol.
What conditions is Metoprolol approved to treat?
Metoprolol is approved for the treatment of:
- Hypertension (high blood pressure)
- Angina pectoris (chest pain related to heart disease)
- Heart failure
- Myocardial infarction prophylaxis (prevention of heart attack)
How does Metoprolol help with these illnesses?
Metoprolol is a beta blocker that works by affecting the response to certain nerve impulses in your heart, thus causing the heart to beat with less force and speed. It also helps to widen blood vessels, which leads to decreased blood pressure, enhanced blood flow and reduced strain on the heart. As a selective beta1 receptor blocker, Metoprolol mainly affects these receptors found predominantly in cardiac tissue which makes it more favorable for cardiac issues compared to Carvedilol. Its action on adrenergic receptors can also play roles in its effectiveness as an anti-hypertensive drug. Since it does not significantly affect alpha-receptors like Carvedilol does, it is sometimes prescribed when a patient has specific contraindications such as peripheral vascular disease or asthma where non-selective beta blockers could cause complications.
How effective are both Carvedilol and Metoprolol?
Both carvedilol and metoprolol have established histories of effectively managing hypertension and heart failure, with the former being approved by the FDA in 1995 and the latter gaining approval as early as 1978. They act on similar adrenergic receptors but differ in their specificity; carvedilol is a non-selective beta blocker that also blocks alpha-1 receptors, while metoprolol specifically targets beta-1 receptors.
The effectiveness of these two drugs was directly compared in studies such as COMET (Carvedilol Or Metoprolol European Trial) conducted in 2003. It concluded that patients receiving carvedilol had lower mortality rates than those treated with metoprolol.
A review published in 2010 suggested that both are effective at reducing blood pressure, improving ejection fraction, and increasing exercise tolerance. However, due to its vasodilation properties resulting from alpha blocking activity, carvedilor may offer additional benefits such as improved renal function and reduced peripheral vascular resistance.
A meta-analysis completed in 2007 pointed out that while both medication classes are similarly effective for high blood pressure control, there might be differences when used to treat congestive heart failure or following myocardial infarction. Specifically, it noted that metoprolol might not be the first choice for individuals who need a beta-blocker after having a heart attack because it's less beneficial than other medications (like carvedilol).
Nonetheless, like many medical decisions about drug therapy options will depend on patient-specific factors including comorbidity profile - what other medical conditions they have - alongside potential side effects which can range from fatigue to sexual dysfunction.
Related trials for carvedilol and metoprolol
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Carvedilol typically prescribed?
Oral doses of Carvedilol typically start from 3.125 mg twice a day for heart failure, and after two weeks if well-tolerated, the dosage can be increased to 6.25 mg twice daily. For hypertension management, it usually starts at 6.25 mg twice daily and may increase up to 50 mg per day if required. On the other hand, Metoprolol dosages generally range from 25–100mg once daily for treating hypertension or angina, but in managing heart failure, it could go up as high as 200 mg/day under doctor's guidance. In both medications' case, children and adolescents' dosages must be determined by a healthcare provider considering individual health conditions and responses to therapy.
At what dose is Metoprolol typically prescribed?
Metoprolol therapy is typically initiated at a dosage of 25-100 mg/day, depending on the patient's medical condition and tolerance. The dose can then be increased to up to 400 mg/day, divided into two doses taken approximately 12 hours apart. A maximum dosage of up to 450mg per day, divided into two or three doses and spaced evenly throughout the day may be considered if there is no adequate response after several weeks of treatment at lower dosages. Always remember that changes in dosing should only be made under the direct supervision of your healthcare provider.
What are the most common side effects for Carvedilol?
The most commonly observed side effects of Carvedilol include:
- Dizziness, lightheadedness or feeling faint
- General tiredness and weakness (asthenia)
- Low blood pressure when standing up quickly from a sitting or lying position
- Swelling in the hands, ankles, feet or lower legs
- Difficulty breathing during physical activity
- Diarrhea
- Weight gain -Nausea.
On the other hand, metoprolol may cause these common side effects:
-Tiredness and dizziness. -Slower heart rate. -Diarrhea. -Dry mouth. If you have dry mouth while taking this drug, -Nausea or vomiting. -Impotence. This is an inability to maintain an erection suitable for sexual intercourse.
Are there any potential serious side effects for Carvedilol?
In rare cases, carvedilol can cause potentially serious side effects:
- Hypersensitivity reactions such as skin rash, itching or hives, swelling of the face or hands and lips
- Unusual weight gain or swelling in your ankles or feet
- Shortness of breath; even though these drugs are used to treat high blood pressure and heart conditions, they might lead to worsening heart failure symptoms.
- Slow or uneven heartbeats
- Lightheadedness leading to fainting spells
- High blood sugar levels - increased thirst, increased urination frequency, dry mouth
Severe liver damage is also a risk with carvedilol. Although this is very rare but if you notice any signs like upper stomach pain, loss of appetite that leads to rapid weight loss, dark urine coloration and jaundice (yellowing of the skin/eyes), medical attention should be sought immediately.
If you have an allergic reaction while on Carvedilol (rare but possible) that causes difficulty breathing; swelling in your face/lips/tongue/throat seek emergency help right away.
Please note that most people don't get severe side effects from taking carvedilol. Always consult with a healthcare professional before making changes based on these potential risks.
What are the most common side effects for Metoprolol?
Focusing on Metoprolol, the following side effects can manifest:
- Tiredness or dizziness
- Slow heartbeat
- Weight gain
- Depression or confusion
- Shortness of breath and trouble breathing
- Cold hands and feet
- Swelling of the hands, ankles, or feet -Nausea or vomiting.
While these are general potential symptoms that may arise from using Metoprolol, it is crucial to remember that individual patients might have different reactions based on their health status, other medications they might be taking concurrently along with many other factors. Always consult a healthcare provider before starting any new medication regime.
Are there any potential serious side effects for Metoprolol?
While Metoprolol is generally well-tolerated, it does have the potential to cause some severe side effects. If you experience any of the following symptoms while taking this medication, seek medical attention immediately:
- Signs of a serious allergic reaction such as hives; difficulty breathing; swelling in your face, lips, tongue or throat
- Unusual mood changes or behaviors including confusion or memory problems
- Blue-colored fingers and toes due to decreased blood flow
- Chest pain that radiates to the jaw or shoulder and comes with nausea
- A very slow heart rate (fewer than 60 beats per minute)
- Feelings of faintness like you might pass out
- Shortness of breath even with mild exertion,
Remember that these side effects are not common but can be serious if they do occur. Always consult your healthcare provider if you have concerns about any new symptoms while taking Metoprolol.
Contraindications for Carvedilol and Metoprolol?
Carvedilol and Metoprolol, like most other beta-blockers, may worsen symptoms of heart failure in some patients. If you notice shortness of breath, swelling ankles/feet, or unusual tiredness or weight gain, please seek immediate medical attention.
Neither Carvedilol nor Metoprolol should be taken if you have severe liver disease. Always tell your physician which medications you are on; certain drugs like calcium channel blockers (verapamil and diltiazem), class I antiarrhythmics (disopyramide) and centrally acting antihypertensive drugs will require careful monitoring to prevent dangerous interactions with Carvedilol and Metoprolol.
Also note that abrupt discontinuation of either Carvedilol or Metoprolol can lead to rapid worsening of angina symptoms. It is recommended that the dosage be gradually reduced over 1-2 weeks under a doctor's supervision when stopping these medications.
How much do Carvedilol and Metoprolol cost?
For the brand name versions of these drugs:
- The price of 60 tablets of Coreg (Carvedilol, 3.125 mg) averages around $200, which works out to approximately $3–6/day depending on your dose.
- The price for a similar quantity of Toprol XL (Metoprolol Succinate, 25 mg) hovers around $225 and costs about $4 per day.
Thus, if you are in the higher dosage range for Carvedilol (i.e., 50 mg/day or higher), then brand-name Toprol XL is less expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which drug is right for you.
Regarding their generic versions:
- Generic carvedilol can be found with prices ranging from as low as $0.10 to up to $1 per day based upon typical dosages between 12.5mg and up to even 100mg daily.
- Metoprolol succinate's pricing starts at roughly at about $0.15/day when purchasing larger pack sizes and can go up to approximately $.90/day depending on your prescribed dosage level.
These costs may vary significantly depending upon location and specific pharmacy used but typically remain lower than their branded counterparts.
Popularity of Carvedilol and Metoprolol
Carvedilol, in generic form as well as brand names such Coreg, was estimated to have been prescribed to about 7.9 million people in the US in 2020. Carvedilol accounted for just over 15% of beta-blocker prescriptions in the US. It is also classified as a non-selective third-generation beta-blocker and has been generally increasing in prevalence since its approval by the FDA.
Metoprolol, including brand versions such Lopressor and Toprol XL, was prescribed to approximately 18 million people in the USA during 2020. In the US, metoprolol accounts for around 35% of beta-blockers prescriptions which makes it one of the most commonly used drugs within this class. The prevalence of metoprolol has remained steady over recent years despite being on market longer than carvedilol; this might be attributed to its cardioselectivity at lower doses that tends to result with fewer side effects compared with non-selective agents like carvedilol.
Conclusion
Both Carvedilol and Metoprolol are commonly used in the management of hypertension and heart failure, with a healthy track record backed by numerous clinical studies. They fall under the category of beta-blockers but differ slightly in their mechanisms. While both affect beta-1 receptors which primarily reside in cardiac tissue, carvedilol also blocks alpha-1 receptors found on vascular smooth muscle (providing additional dilation to blood vessels), and beta-2 receptors located mostly in the lungs.
Carvedilol is often chosen for patients with congestive heart failure due to its unique mechanism of action that affects multiple receptor types. On the other hand, metoprolol is typically used as a first-line treatment for high blood pressure, angina pectoris (chest pain usually caused by lack of oxygen to the heart muscle), or after a heart attack.
Both drugs are available as generics which can be cost-effective especially for those without insurance coverage. There may be an initial adjustment period where dosage might need fine-tuning based on patient response.
As far as side effects go, they share common ones such as dizziness or light-headedness due to reduced blood pressure. However, given its additional activity at alpha and beta-2 receptors, carvedilol may have different side effect profiles including weight gain and shortness of breath compared to metoprolol. Like all medication changes or initiations it is important for patients to monitor themselves closely; any worsening conditions should prompt immediate medical attention.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Ramahi, T. M., Rohlfs, K., Sheynberg, N., Engle, K. M., & Longo, M. D. (2001, July). Clinic Dosing of β Blockers in Chronic Heart Failure. Congestive Heart Failure. Wiley.http://doi.org/10.1111/j.1527-5299.2001.00253.x
- MOLENAAR, P., CHRIST, T., RAVENS, U., & KAUMANN, A. (2006, January). Carvedilol blocks β2- more than β1-adrenoceptors in human heart. Cardiovascular Research. Oxford University Press (OUP).http://doi.org/10.1016/j.cardiores.2005.08.024
- Feuerstein, G. Z., & Ruffolo, R. R. (1996, April 2). Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. European Heart Journal. Oxford University Press (OUP).http://doi.org/10.1093/eurheartj/17.suppl_b.24
- Keating, G. M., & Jarvis, B. (2003). Carvedilol. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200363160-00006
- Stoschitzky, K., Koshucharova, G., Zweiker, R., Maier, R., Watzinger, N., Fruhwald, F. M., & Klein, W. (2001, June). Differing beta‐blocking effects of carvedilol and metoprolol. European Journal of Heart Failure. Wiley.http://doi.org/10.1016/s1388-9842(01)00126-x
- Hagmeyer, K. O., & Stein, J. (2001, November). Hepatotoxicity Associated with Carvedilol. Annals of Pharmacotherapy. SAGE Publications.http://doi.org/10.1345/aph.10239
- Metra, M., Giubbini, R., Nodari, S., Boldi, E., Modena, M. G., & Cas, L. D. (2000, August). Differential Effects of β-Blockers in Patients With Heart Failure. Circulation. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1161/01.cir.102.5.546
- Brogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1977, November). Metoprolol. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-197714050-00001
- Kendall, M. J., John, V. A., Quarterman, C. P., & Welling, P. G. (1980). A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metoprolol. European Journal of Clinical Pharmacology. Springer Science and Business Media LLC.http://doi.org/10.1007/bf00562615
- Aneja, P., Srinivas, A., & Biswas, A. D. (2007, May 1). Comparative clinical study of the efficacy and safety of a S-metoprolol ER tablet versus a racemate metoprolol ER tablet in patients with chronic stable angina. Int. Journal of Clinical Pharmacology and Therapeutics. Dustri-Verlgag Dr. Karl Feistle.http://doi.org/10.5414/cpp45253